174 related articles for article (PubMed ID: 22775340)
21. ABCG2: the key to chemoresistance in cancer stem cells?
An Y; Ongkeko WM
Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1529-42. PubMed ID: 19708828
[TBL] [Abstract][Full Text] [Related]
22. Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.
Yoo YD; Lee DH; Cha-Molstad H; Kim H; Mun SR; Ji C; Park SH; Sung KS; Choi SA; Hwang J; Park DM; Kim SK; Park KJ; Kang SH; Oh SC; Ciechanover A; Lee YJ; Kim BY; Kwon YT
EMBO Rep; 2017 Jan; 18(1):150-168. PubMed ID: 27993939
[TBL] [Abstract][Full Text] [Related]
23. Sinoporphyrin sodium, a novel sensitizer, triggers mitochondrial-dependent apoptosis in ECA-109 cells via production of reactive oxygen species.
Wang H; Wang X; Zhang S; Wang P; Zhang K; Liu Q
Int J Nanomedicine; 2014; 9():3077-90. PubMed ID: 25028547
[TBL] [Abstract][Full Text] [Related]
24. Detoxification of oxidative stress in glioma stem cells: mechanism, clinical relevance, and therapeutic development.
Kim SH; Kwon CH; Nakano I
J Neurosci Res; 2014 Nov; 92(11):1419-24. PubMed ID: 25043479
[TBL] [Abstract][Full Text] [Related]
25. Enhancing chemosensitivity in ABCB1- and ABCG2-overexpressing cells and cancer stem-like cells by an Aurora kinase inhibitor CCT129202.
Cheng C; Liu ZG; Zhang H; Xie JD; Chen XG; Zhao XQ; Wang F; Liang YJ; Chen LK; Singh S; Chen JJ; Talele TT; Chen ZS; Zhong FT; Fu LW
Mol Pharm; 2012 Jul; 9(7):1971-82. PubMed ID: 22632055
[TBL] [Abstract][Full Text] [Related]
26. Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.
Chen YH; McGowan LD; Cimino PJ; Dahiya S; Leonard JR; Lee DY; Gutmann DH
Cell Rep; 2015 Mar; 10(11):1899-912. PubMed ID: 25772366
[TBL] [Abstract][Full Text] [Related]
27. Targeting glioma stem cells in vivo by a G-quadruplex-stabilizing synthetic macrocyclic hexaoxazole.
Nakamura T; Okabe S; Yoshida H; Iida K; Ma Y; Sasaki S; Yamori T; Shin-Ya K; Nakano I; Nagasawa K; Seimiya H
Sci Rep; 2017 Jun; 7(1):3605. PubMed ID: 28620243
[TBL] [Abstract][Full Text] [Related]
28. Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells.
Shen D; Guo CC; Wang J; Qiu ZK; Sai K; Yang QY; Chen YS; Chen FR; Wang J; Panasci L; Chen ZP
Oncol Rep; 2015 Nov; 34(5):2715-21. PubMed ID: 26329778
[TBL] [Abstract][Full Text] [Related]
29. Bufalin Induces Apoptosis and Improves the Sensitivity of Human Glioma Stem-Like Cells to Temozolamide.
Liu J; Zhang Y; Sun S; Zhang G; Jiang K; Sun P; Zhang Y; Yao B; Sui R; Chen Y; Guo X; Tang T; Shi J; Liang H; Piao H
Oncol Res; 2019 Mar; 27(4):475-486. PubMed ID: 29793559
[TBL] [Abstract][Full Text] [Related]
30. Tumor targeting DVDMS-nanoliposomes for an enhanced sonodynamic therapy of gliomas.
Sun Y; Wang H; Wang P; Zhang K; Geng X; Liu Q; Wang X
Biomater Sci; 2019 Feb; 7(3):985-994. PubMed ID: 30601475
[TBL] [Abstract][Full Text] [Related]
31. siRNA targeting stathmin inhibits invasion and enhances chemotherapy sensitivity of stem cells derived from glioma cell lines.
Song Y; Mu L; Han X; Liu X; Fu S
Acta Biochim Biophys Sin (Shanghai); 2014 Dec; 46(12):1034-40. PubMed ID: 25348735
[TBL] [Abstract][Full Text] [Related]
32. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.
Liu A; Feng B; Gu W; Cheng X; Tong T; Zhang H; Hu Y
Int J Oncol; 2013 Apr; 42(4):1399-407. PubMed ID: 23416969
[TBL] [Abstract][Full Text] [Related]
33. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
34. In vitro sonodynamic cytotoxicity in regulated cavitation conditions.
El Maalouf J; Béra JC; Alberti L; Cathignol D; Mestas JL
Ultrasonics; 2009 Feb; 49(2):238-43. PubMed ID: 18930303
[TBL] [Abstract][Full Text] [Related]
35. Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells.
Zhou W; Sun M; Li GH; Wu YZ; Wang Y; Jin F; Zhang YY; Yang L; Wang DL
Oncol Rep; 2013 Oct; 30(4):1793-801. PubMed ID: 23846672
[TBL] [Abstract][Full Text] [Related]
36. Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics.
Boesch M; Zeimet AG; Rumpold H; Gastl G; Sopper S; Wolf D
Stem Cells Transl Med; 2015 Sep; 4(9):1028-32. PubMed ID: 26136502
[TBL] [Abstract][Full Text] [Related]
37. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
Hsu CC; Chang WC; Hsu TI; Liu JJ; Yeh SH; Wang JY; Liou JP; Ko CY; Chang KY; Chuang JY
J Biomed Sci; 2016 Nov; 23(1):81. PubMed ID: 27863490
[TBL] [Abstract][Full Text] [Related]
38. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z
Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986
[TBL] [Abstract][Full Text] [Related]
39. Metabolic state of glioma stem cells and nontumorigenic cells.
Vlashi E; Lagadec C; Vergnes L; Matsutani T; Masui K; Poulou M; Popescu R; Della Donna L; Evers P; Dekmezian C; Reue K; Christofk H; Mischel PS; Pajonk F
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):16062-7. PubMed ID: 21900605
[TBL] [Abstract][Full Text] [Related]
40. Killing Glioma 'Stem-like' Cells via Drug-Induced Relocation of Endosomal Urokinase Proteins.
Gorin FA; Pasupuleti N; Mahajan D; Dugar S
Anticancer Agents Med Chem; 2017; 17(1):40-47. PubMed ID: 27357540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
